- Report
- March 2025
- 175 Pages
Global
From €4229EUR$4,490USD£3,617GBP
- Report
- March 2025
- 175 Pages
Global
From €4229EUR$4,490USD£3,617GBP
- Report
- April 2025
- 200 Pages
Global
From €4229EUR$4,490USD£3,617GBP
- Report
- March 2025
- 200 Pages
Global
From €4229EUR$4,490USD£3,617GBP
- Report
- March 2025
- 150 Pages
Global
From €4569EUR$4,850USD£3,907GBP
- Report
- May 2024
- 134 Pages
Global
From €6122EUR$6,499USD£5,235GBP
- Report
- May 2024
- 130 Pages
Global
From €6122EUR$6,499USD£5,235GBP
- Report
- May 2024
- 137 Pages
Global
From €6122EUR$6,499USD£5,235GBP
- Report
- May 2024
- 130 Pages
Global
From €6122EUR$6,499USD£5,235GBP
- Report
- September 2023
- 110 Pages
Global
From €5605EUR$5,950USD£4,793GBP
- Report
- April 2024
- 138 Pages
Global
From €2825EUR$2,999USD£2,416GBP
- Report
- November 2021
- 109 Pages
Global
From €4239EUR$4,500USD£3,625GBP
- Report
- November 2023
- 140 Pages
Global
From €4192EUR$4,450USD£3,584GBP
- Report
- April 2023
- 200 Pages
United States
From €3532EUR$3,750USD£3,021GBP
- Report
- April 2023
- 394 Pages
Global
From €7065EUR$7,500USD£6,041GBP
- Report
- March 2024
- 200 Pages
Global
From €3909EUR$4,150USD£3,343GBP
- Report
- February 2024
- 120 Pages
Global
From €4474EUR$4,750USD£3,826GBP
- Report
- April 2023
- 116 Pages
Global
From €4474EUR$4,750USD£3,826GBP
- Report
- January 2024
- 78 Pages
Global
From €3500EUR$3,980USD£3,098GBP
- Report
- May 2022
- 78 Pages
Global
From €3500EUR$3,980USD£3,098GBP

Carmustine is a chemotherapy drug used to treat lymphoma, a type of cancer that affects the lymphatic system. It is a nitrogen mustard alkylating agent, meaning it works by damaging the DNA of cancer cells, preventing them from growing and dividing. It is usually administered intravenously, and is often used in combination with other drugs. Common side effects include nausea, vomiting, hair loss, and fatigue.
Carmustine is a widely used drug in the treatment of lymphoma, and is available in both generic and branded forms. It is typically prescribed by oncologists and hematologists, and is available in both oral and injectable forms. It is also used in combination with other drugs, such as rituximab, to treat more advanced forms of lymphoma.
The Carmustine market is highly competitive, with a number of companies offering branded and generic versions of the drug. Some of the major players in the market include Bristol-Myers Squibb, Pfizer, Merck, Novartis, and Teva Pharmaceuticals. Show Less Read more